UNSPSC 51311609: Nedocromil calcium

This classification denotes a histamine-1 receptor antagonist C19H15NO7.Ca, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0983W479HH, chemically known as calcium 9-ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4h-pyrano(3,2-g)quinoline-2,8-dicarboxylate (1:1), but more generally known as nedocromil calcium, which bears US NIH Compound Identifier 68731. European Medicines Agency schedules Nedocromil calcium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14633MIG.

UNSPSC 51311609 Nedocromil calcium is a Commodity code that classifies pharmaceutical products; however, recent state and local procurement activity under this code does not align with its nominal scope. The single recent opportunity posted shows Seminole County, Florida issuing an IFB (IFB60459723LAS, due July 26, 2023) for naloxone and drug deactivation systems—products unrelated to nedocromil calcium, an inhaled asthma preventive medication. The mismatch suggests either miscoding in the opportunity posting or limited current activity in nedocromil calcium procurement at the state and local level. Issuing bodies pursuing pharmaceutical items typically include county health departments, school districts (for student health services), and state Medicaid agencies, though the recent opportunities block provides no additional examples of nedocromil calcium sourcing.

Geographic data is insufficient to characterize meaningful patterns. The single opportunity appears in Florida. State and local procurement of nedocromil calcium—if it occurs under this code—does not generate visible recent activity in the available records. Business development professionals should verify whether nedocromil calcium is actively sourced through state or local channels in their target markets, as the code shows no substantive recent opportunities aligned with the product category.